197 related articles for article (PubMed ID: 28585031)
1.
Tuominen H; Haarala A; Tikkakoski A; Korkola P; Kähönen M; Nikus K; Sipilä K
J Nucl Cardiol; 2019 Apr; 26(2):394-400. PubMed ID: 28585031
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
[TBL] [Abstract][Full Text] [Related]
3. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
4. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
[TBL] [Abstract][Full Text] [Related]
5. Novel ECG parameters are strongly associated with inflammatory
Sipilä K; Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K
Int J Cardiol; 2017 Dec; 249():454-460. PubMed ID: 29121750
[TBL] [Abstract][Full Text] [Related]
6.
Omote K; Naya M; Koyanagawa K; Aikawa T; Manabe O; Nagai T; Kamiya K; Kato Y; Komoriyama H; Kuzume M; Tamaki N; Anzai T
J Nucl Cardiol; 2020 Dec; 27(6):2135-2143. PubMed ID: 30610523
[TBL] [Abstract][Full Text] [Related]
7. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
Manabe O; Yoshinaga K; Ohira H; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Masuda A; Magota K; Nishimura M; Tamaki N
Ann Nucl Med; 2014 Aug; 28(7):656-63. PubMed ID: 24889126
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events.
Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K; Sipilä K
J Nucl Cardiol; 2021 Feb; 28(1):199-205. PubMed ID: 30815833
[TBL] [Abstract][Full Text] [Related]
9. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of serial quantitative evaluation of
Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
Lucinian YA; Martineau P; Poenaru R; Tremblay-Gravel M; Cadrin-Tourigny J; Harel F; Pelletier-Galarneau M
J Nucl Cardiol; 2023 Dec; 30(6):2490-2500. PubMed ID: 37258950
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
14. 18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes.
Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K; Sipilä K
J Nucl Cardiol; 2020 Feb; 27(1):109-117. PubMed ID: 29721764
[TBL] [Abstract][Full Text] [Related]
15. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
16. Utility of new FDG-PET/CT guidelines for diagnosing cardiac sarcoidosis in patients with implanted cardiac pacemakers for atrioventricular block.
Tanabe S; Nakano Y; Ando H; Fujimoto M; Onishi T; Ohashi H; Kuno S; Naito K; Waseda K; Takahashi H; Suzuki Y; Fukuta M; Amano T
Sci Rep; 2024 Apr; 14(1):7825. PubMed ID: 38570621
[TBL] [Abstract][Full Text] [Related]
17. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
Nery PB; Beanlands RS; Nair GM; Green M; Yang J; McArdle BA; Davis D; Ohira H; Gollob MH; Leung E; Healey JS; Birnie DH
J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
[TBL] [Abstract][Full Text] [Related]
18. Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis.
Sperry BW; Ibrahim A; Negishi K; Negishi T; Patel P; Popović ZB; Culver D; Brunken R; Marwick TH; Tamarappoo B
Am J Cardiol; 2017 May; 119(10):1663-1669. PubMed ID: 28343598
[TBL] [Abstract][Full Text] [Related]
19. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
Osborne MT; Hulten EA; Singh A; Waller AH; Bittencourt MS; Stewart GC; Hainer J; Murthy VL; Skali H; Dorbala S; Di Carli MF; Blankstein R
J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
